AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
-3.93%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$963M
AUM Growth
+$963M
(+78%)
Cap. Flow
+$458M
Cap. Flow
% of AUM
47.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Integral Ad Science
IAS
|
$468M |
Top Sells
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$9.26M |
Sector Composition
| 1 | Communication Services | 53.03% |
| 2 | Consumer Discretionary | 39.44% |
| 3 | Healthcare | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Integral Ad Science
IAS
$1.49B
| $468M | 48.54% | +22,722,770 | New | +$468M |
|
2
DraftKings
DKNG
$23.8B
| $380M | 39.44% | 7,284,008 | – | – |
|
|
TBIO
3
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $51.6M | 5.35% | 1,872,115 | – | – |
|
4
Roku
ROKU
$14.2B
| $26.5M | 2.75% | 57,707 | – | – |
|
5
Snap
SNAP
$12.1B
| $16.7M | 1.74% | 245,559 | – | – |
|
|
BCYC
6
Bicycle Therapeutics
BCYC
$511M
| $9.34M | 0.97% | 307,696 -305,000 | -50% | -$9.26M |
|
|
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.94M | 0.51% | 574,996 | – | – |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $3.83M | 0.4% | 209,505 | – | – |
|
9
Larimar Therapeutics
LRMR
$310M
| $2.87M | 0.3% | 292,184 | – | – |
|